Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Albertini

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Journal for Immunotherapy of Cancer|August 24, 2018
The age of enlightenment in melanoma immunotherapyMark R Albertini
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|March 21, 2012
OMIP-008: measurement of Th1 and Th2 cytokine polyfunctionality of human T cellsCindy L Zuleger, Mark R Albertini
WMJ : Official Publication of the State Medical Society of Wisconsin|January 5, 2016
Incidence, Survival, and Mortality of Malignant Cutaneous Melanoma in Wisconsin, 1995-2011Molly Peterson, Mark R Albertini, Patrick Remington
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 26, 2007
MAD-CT-2 identified as a novel melanoma cancer-testis antigen using phage immunoblot analysisJason A Dubovsky, Mark R Albertini, Douglas G McNeel
Transfusion Medicine Reviews|July 13, 2004
Dendritic cell-based immunotherapy for cancer and relevant challenges for transfusion medicineChing Y Voss, Mark R Albertini, James S Malter
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
Native and genetically engineered anti-disialoganglioside monoclonal antibody treatment of melanomaMark R Albertini, Jacquelyn A Hank, Paul M Sondel
Seminars in Nuclear Medicine|October 16, 2020
FDG PET/CT for Assessment of Immune Therapy: Opportunities and Understanding PitfallsSteve Y Cho, Daniel T Huff, Robert Jeraj, et al.
Case Reports in Gastrointestinal Medicine|July 26, 2021
Retrograde Balloon-Assisted Deep Enteroscopy in the Diagnosis of Metastatic MelanomaWilliam Barge, Mark R Albertini, Christopher Cold, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
Hydrodynamic limb vein delivery of a xenogeneic DNA cancer vaccine effectively induces antitumor immunityZane C Neal, Mary K Bates, Mark R Albertini, et al.
Expert Opinion on Investigational Drugs|June 25, 2009
The development of antibody-IL-2 based immunotherapy with hu14.18-IL2 (EMD-273063) in melanoma and neuroblastomaBrett H Yamane, Jacquelyn A Hank, Mark R Albertini, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Journal for Immunotherapy of Cancer|August 24, 2018
The age of enlightenment in melanoma immunotherapyMark R Albertini
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|March 21, 2012
OMIP-008: measurement of Th1 and Th2 cytokine polyfunctionality of human T cellsCindy L Zuleger, Mark R Albertini
WMJ : Official Publication of the State Medical Society of Wisconsin|January 5, 2016
Incidence, Survival, and Mortality of Malignant Cutaneous Melanoma in Wisconsin, 1995-2011Molly Peterson, Mark R Albertini, Patrick Remington
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 26, 2007
MAD-CT-2 identified as a novel melanoma cancer-testis antigen using phage immunoblot analysisJason A Dubovsky, Mark R Albertini, Douglas G McNeel
Transfusion Medicine Reviews|July 13, 2004
Dendritic cell-based immunotherapy for cancer and relevant challenges for transfusion medicineChing Y Voss, Mark R Albertini, James S Malter
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
Native and genetically engineered anti-disialoganglioside monoclonal antibody treatment of melanomaMark R Albertini, Jacquelyn A Hank, Paul M Sondel
Seminars in Nuclear Medicine|October 16, 2020
FDG PET/CT for Assessment of Immune Therapy: Opportunities and Understanding PitfallsSteve Y Cho, Daniel T Huff, Robert Jeraj, et al.
Case Reports in Gastrointestinal Medicine|July 26, 2021
Retrograde Balloon-Assisted Deep Enteroscopy in the Diagnosis of Metastatic MelanomaWilliam Barge, Mark R Albertini, Christopher Cold, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
Hydrodynamic limb vein delivery of a xenogeneic DNA cancer vaccine effectively induces antitumor immunityZane C Neal, Mary K Bates, Mark R Albertini, et al.
Expert Opinion on Investigational Drugs|June 25, 2009
The development of antibody-IL-2 based immunotherapy with hu14.18-IL2 (EMD-273063) in melanoma and neuroblastomaBrett H Yamane, Jacquelyn A Hank, Mark R Albertini, et al.
Pageof 7